Promoting signal for electrical stimulation
By delivering signals and electrode configurations in different spatial ranges, the current diffusion control problem in medical devices is solved, low-power consumption and efficient nerve cell activation are achieved, and the perception effect of the auditory system is improved.
Patent Information
- Application Number
- CN202380028116.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-17
- Filing Date
- 2023-03-10
- Publication Date
- 2024-11-12
AI Technical Summary
When existing medical devices activate and depolarize nerve cells, it is difficult to effectively control the current diffusion range, resulting in high power consumption and low efficiency problems.
Depolarization and activation of nerve cells is controlled by delivering promotion and stimulation signals with different spatial ranges, using multiple electrode configurations (such as monopole, focused multipole, biphase stimulation) to control depolarization and activation of nerve cells, achieving lower overall current levels and Power consumption.
The effect of obtaining focused stimulation at lower current levels and power consumption is achieved, improving the perceived details and efficiency of the auditory system.
Smart Images

Figure CN118946382A_ABST
Abstract
Description
Technical Field
[0001] The present invention generally relates to the use of boost signals and electrical stimulation signals. Background Art
[0002] Medical devices have provided a wide range of therapeutic benefits to recipients over the last several decades. Medical devices may include internal or implantable components / devices, external or wearable components / devices, or combinations thereof (e.g., devices having external components that communicate with implantable components). Medical devices, such as traditional hearing aids, partially or fully implantable hearing prostheses (e.g., bone conduction devices, mechanical stimulators, cochlear implants, etc.), pacemakers, defibrillators, functional electrical stimulation devices, and other medical devices, have been successful over the years in performing life-saving and / or lifestyle-improving functions and / or recipient monitoring.
[0003] Over the years, the types of medical devices and the range of functions performed by them have increased. For example, many medical devices, sometimes referred to as "implantable medical devices," now typically include one or more instruments, devices, sensors, processors, controllers, or other functional mechanical or electrical components that are permanently or temporarily implanted in a recipient's body. These functional devices are typically used to diagnose, prevent, monitor, treat, or manage disease / injury or its symptoms, or to study, replace, or modify anatomical structures or physiological processes. Many of these functional devices utilize power and / or data received from an external device that is part of or operates in conjunction with the implantable component. Summary of the invention
[0004] In one aspect, a method is provided. The method includes: delivering at least one stimulatory signal having a first spatial extent to partially depolarize a recipient's neural cells; and delivering at least one stimulatory signal having a second spatial extent to activate at least a subset of the recipient's partially depolarized neural cells, wherein the second spatial extent is different from the first spatial extent.
[0005] In another aspect, a method is provided. The method includes: delivering at least a first facilitation pulse having a first polarity to a region of neural cells using a first electrode configuration associated with a first current spread; and after delivering the at least first facilitation pulse, delivering at least one biphasic stimulation signal to only a portion of the region of neural cells using a second electrode configuration associated with a second current spread that is different from the first current spread.
[0006] On the other hand, an implantable medical device is provided. The implantable medical device includes: one or more input devices, the one or more input devices are configured to receive at least one input signal; one or more processors, the one or more processors are configured to convert the at least one input signal into at least one output signal; an electrode array, the electrode array is configured to be implanted in a recipient; and a stimulator unit, the stimulator unit is configured to generate at least one electrical stimulation signal based on the at least one output signal, and deliver the at least one electrical stimulation signal to a cell area of the recipient via the electrode array, wherein, before delivering the at least one electrical stimulation signal to the cell area, the stimulator unit is configured to generate at least a first facilitation pulse, and deliver the at least first facilitation pulse to the cell area via the electrode array, wherein the at least first facilitation pulse is delivered via a first electrode configuration and is configured to depolarize only the cell portion within the cell area.
[0007] In another aspect, a medical device is provided. The medical device includes: one or more processors; and at least one stimulator unit, the at least one stimulator unit being configured to: generate at least a first facilitation pulse having a first polarity, deliver the at least first facilitation pulse to a cell region of a recipient using a first electrode configuration having an associated first current spread, generate at least one stimulation signal in response to instructions received from the one or more processors, and after delivering the at least first facilitation pulse, deliver the at least one stimulation signal to the cell region of the recipient using a second electrode configuration having an associated second current spread different from the first current spread. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] Embodiments of the present invention are described herein with reference to the accompanying drawings, in which:
[0009] Figure 1A is a schematic diagram illustrating a cochlear implant system with which aspects of the technology presented herein may be implemented;
[0010] Figure 1B Yes Wear Figure 1A A side view of a recipient of a sound processing unit of a cochlear implant system;
[0011] Figure 1C yes Figure 1A A schematic diagram of components of a cochlear implant system;
[0012] Figure 1D yes Figure 1A Block diagram of a cochlear implant system;
[0013] Figure 2It is a diagram showing the stages of an idealized action potential as it passes through a nerve cell;
[0014] Figure 3 is a schematic diagram illustrating a facilitating signal and a stimulating signal according to certain embodiments presented herein;
[0015] Figure 4A , 4B and 4C are schematic diagrams illustrating the spatial extent of an electrical signal according to certain embodiments presented herein;
[0016] Figure 5A is a schematic diagram illustrating a facilitating signal and a stimulating signal according to certain embodiments presented herein;
[0017] Figure 5B is another schematic diagram illustrating promotional signals and stimulation signals according to certain embodiments presented herein;
[0018] Fig. 6A is a schematic diagram illustrating a facilitation signal and three stimulation signals according to certain embodiments presented herein;
[0019] Figure 6B is shown with Fig. 6A Schematic diagram of the current spread associated with the promotion signal and three stimulation signals;
[0020] Figure 6C is a schematic diagram illustrating a facilitation signal and two stimulation signals according to certain embodiments presented herein;
[0021] Fig.6D is a schematic diagram illustrating a facilitation signal and three stimulation signals according to certain embodiments presented herein;
[0022] Fig. 6E is a schematic diagram illustrating a facilitation signal and three stimulation signals according to certain embodiments presented herein;
[0023] Figure 7 is a flow chart illustrating another exemplary method according to certain embodiments presented herein;
[0024] Figure 8 is a flow chart illustrating yet another exemplary method according to certain embodiments presented herein;
[0025] Fig. 9 is a schematic diagram illustrating a stimulation system with which aspects of the technology presented herein may be implemented; and
[0026] Fig.10 is a schematic diagram illustrating a vestibular stimulator system with which aspects of the technology presented herein may be implemented; and
[0027] Fig.11 is a schematic diagram illustrating a retinal prosthesis system with which aspects of the technology presented herein may be implemented. DETAILED DESCRIPTION
[0028] The present invention provides a technology for delivering electrical (current) stimulation to a recipient. More specifically, according to certain embodiments presented herein, at least one stimulating signal having a first spatial range is delivered to a recipient in order to partially depolarize a neural cell of the recipient. At least one stimulation signal having a second spatial range is delivered to a recipient in order to activate at least a subset of partially depolarized neural cells of the recipient. The second spatial range of at least one stimulation signal is different from (e.g., greater than or less than) the first spatial range of at least one stimulating signal.
[0029] For ease of description only, the technology presented herein is described primarily with reference to a specific hearing device (i.e., a cochlear implant). It should be understood that the technology presented herein may also be partially or completely implemented by other types of hearing devices and / or other types of implantable medical devices. For example, the technology presented herein may be implemented with a middle ear hearing prosthesis, a bone conduction device, an electro-acoustic prosthesis, an auditory brain stimulator, a direct acoustic stimulator, a combination or variation thereof, or the like. The technology presented herein may also be implemented by a dedicated tinnitus treatment device and a tinnitus treatment device system. In additional embodiments, the technology presented herein may also be implemented by or used in conjunction with an ear wearable, a personal audio device, an in-ear phone, a headset, or the like.
[0030] Figures 1A-1D An exemplary cochlear implant system 102 is shown with which aspects of the technology presented herein may be implemented. Cochlear implant system 102 includes an external component 104 and an implantable component 112. Figures 1A-1D In the example of a cochlear implant, the implantable component is sometimes referred to as a "cochlear implant." Figure 1A The cochlear implant 112 is shown implanted in the head 154 of a recipient, and Figure 1B is a schematic diagram of the outer member 104 worn on the head 154 of the recipient. Figure 1C is another schematic diagram of a cochlear implant system 102, and Figure 1D Additional details of cochlear implant system 102 are shown. For ease of description, the Figures 1A-1D .
[0031] Cochlear implant system 102 includes an external component 104 configured to be attached directly or indirectly to the body of a recipient, and an implantable component 112 configured to be implanted in the body of the recipient. Figures 1A-1DIn the example of , external component 104 includes a sound processing unit 106, and cochlear implant 112 includes an implantable coil 114, an implant body 134, and an elongated stimulation assembly 116 configured to be implanted in the cochlea of a recipient.
[0032] exist Figures 1A-1D In the example of the present invention, the sound processing unit 106 is an outside-the-ear (OTE) sound processing unit, sometimes referred to herein as an OTE component, which is configured to send data and power to the implantable component 112. Generally speaking, the OTE sound processing unit is a component having a generally cylindrical housing 111 and configured to be magnetically coupled to the head of the recipient (e.g., including an integrated external magnet 159 configured to be magnetically coupled to the implantable magnet 141 in the implantable component 112). The OTE sound processing unit 106 also includes an integrated external (head component) coil 108 configured to be inductively coupled to the implantable coil 114.
[0033] It should be appreciated that the OTE sound processing unit 106 is merely illustrative of an external device that can operate with the implantable component 112. For example, in alternative examples, the external component can include a behind-the-ear (BTE) sound processing unit or a micro-BTE sound processing unit and a separate external component. Generally speaking, the BTE sound processing unit includes a housing that is shaped to be worn on the recipient's outer ear and connected to a separate external coil assembly via a cable, wherein the external coil assembly is configured to be magnetically coupled and inductively coupled to the implantable coil 114. It should be appreciated that alternative external components can be located in the recipient's ear canal, worn on the body, etc.
[0034] As described above, cochlear implant system 102 includes sound processing unit 106 and cochlear implant 112. However, as further described below, cochlear implant 112 can operate independently of sound processing unit 106 for at least a period of time to stimulate a recipient. For example, cochlear implant 112 can operate in a first general mode, sometimes referred to as an "external hearing mode," in which sound processing unit 106 captures sound signals that are then used as a basis for delivering stimulation signals to a recipient. Cochlear implant 112 can also operate in a second general mode, sometimes referred to as an "invisible hearing" mode, in which sound processing unit 106 is unable to provide sound signals to cochlear implant 112 (e.g., sound processing unit 106 is not present, sound processing unit 106 is powered off, sound processing unit 106 is malfunctioning, etc.). Thus, in the invisible hearing mode, cochlear implant 112 captures the sound signals itself via an implantable sound sensor and then uses these sound signals as a basis for delivering stimulation signals to a recipient. Further details regarding the operation of cochlear implant 112 in the external hearing mode are provided below, followed by details regarding the operation of cochlear implant 112 in the invisible hearing mode. It should be understood that the references to the external hearing mode and the invisible hearing mode are merely illustrative, and cochlear implant 112 may also operate in alternative modes.
[0035] exist Figure 1A and 1C In the present invention, a cochlear implant system 102 is shown with an external device 110, which is configured to implement various aspects of the technology presented. The external device 110 is a computing device, such as a computer (e.g., a laptop computer, a desktop computer, a tablet computer), a mobile phone, a remote control unit, etc. As further described below, the external device 110 includes a telephone enhancement module, as further described below, which is configured to implement various aspects of the auditory rehabilitation technology presented herein for independent telephone use. The external device 110 and the cochlear implant system 102 (e.g., an OTE sound processing unit 106 or a cochlear implant 112) communicate wirelessly via a two-way communication link 126. The two-way communication link 126 may include, for example, short-range communication, such as a Bluetooth link, a Bluetooth low energy (BLE) link, a proprietary link, etc.
[0036] Return to Figures 1A-1DIn the example of the OTE sound processing unit 106, one or more input devices are configured to receive input signals (e.g., environmental signals from the surrounding environment, such as sound signals, data signals, etc.). The one or more input devices include one or more sound input devices 118 (e.g., one or more external microphones, audio input ports, pickup coils, etc.), one or more auxiliary input devices 128 (e.g., audio ports, such as direct audio input (DAI); data ports, such as universal serial bus (USB) ports; cable ports, etc.), and a wireless transmitter, receiver and / or transceiver referred to as a wireless module 120 (e.g., for communicating with an external device 110). However, it should be understood that the one or more input devices may include additional types of input devices and / or fewer input devices.
[0037] The OTE sound processing unit 106 also includes an external coil 108, a charging coil 130, a tightly coupled transmitter, receiver and / or transceiver (referred to as an RF module 122), at least one rechargeable battery 132, and an external sound processing module 124. The external sound processing module 124 may include, for example, one or more processors and a memory device (memory) including sound processing logic. The memory device may include any one or more of the following: non-volatile memory (NVM), ferroelectric random access memory (FRAM), read-only memory (ROM), random access memory (RAM), magnetic disk storage media device, optical storage media device, flash memory device, electrical, optical or other physical / tangible memory storage device. The one or more processors are, for example, microprocessors or microcontrollers that execute instructions of the sound processing logic stored in the memory device.
[0038] The implantable component 112 includes an implantable main module (implant body) 134, a lead region 136, and an intracochlear stimulation assembly 116, all configured to be implanted beneath the skin / tissue (tissue) 115 of a recipient. The implant body 134 generally includes an airtight sealed housing 138 in which an RF module 140 (e.g., an RF receiver and / or transceiver), a stimulator unit 142, a wireless module 143, an implantable sound processing unit 158, and a rechargeable battery 161 are disposed. The implant body 134 also includes an internal / implantable coil 114, which is generally external to the housing 138 but is electrically connected to the implant via an airtight feedthrough ( Figure 1D ) is connected to the RF module 140.
[0039] As described, the stimulation assembly 116 is configured to be at least partially implanted in the cochlea of the recipient. The stimulation assembly 116 includes a plurality of longitudinally spaced intracochlear electrical stimulation contacts (electrodes) 144 that collectively form a contact or electrode array 146 for delivering electrical stimulation (electrical current) to the cochlea of the recipient.
[0040] The stimulation assembly 116 extends through an opening in the recipient's cochlea (e.g., a cochlear fenestration, a round window, etc.) and has a lead region 136 and an airtight feedthrough ( Figure 1D The implantable component 112 also includes an electrode 144 (not shown) connected to the proximal end of the stimulator unit 142. The lead region 136 includes a plurality of conductors (wires) that electrically couple the electrode 144 to the stimulator unit 142. The implantable component 112 also includes an electrode outside the cochlea, sometimes referred to as an extracochlear electrode (ECE) 139.
[0041] As described, cochlear implant system 102 includes an external coil 108 and an implantable coil 114. External magnet 159 is fixed relative to external coil 108, and implantable magnet 141 is fixed relative to implantable coil 114. The magnets fixed relative to external coil 108 and implantable coil 114 facilitate operational alignment of external coil 108 with implantable coil 114. This operational alignment of the coils enables external component 104 to transmit data and power to implantable component 112 via a tightly coupled wireless link 148 formed between external coil 108 and implantable coil 114. In some examples, tightly coupled wireless link 148 is a radio frequency (RF) link. However, various other types of energy transfer (e.g., infrared (IR), electromagnetic, capacitive, and inductive transfer) may be used to transfer power and / or data from the external component to the implantable component, and thus, Figure 1D Only one exemplary arrangement is shown.
[0042] As described above, the sound processing unit 106 includes an external sound processing module 124. The external sound processing module 124 is configured to convert received input signals (received at one or more of the input devices) into output signals for stimulating the first ear of the recipient (i.e., the external sound processing module 124 is configured to perform sound processing on the input signals received at the sound processing unit 106). In other words, the one or more processors in the external sound processing module 124 are configured to execute the sound processing logic in the memory to convert the received input signals into output signals representing electrical stimulation for delivery to the recipient.
[0043] As stated, Figure 1D An embodiment is shown in which an external sound processing module 124 in the sound processing unit 106 generates an output signal. In an alternative embodiment, the sound processing unit 106 can send less processed information (e.g., audio data) to the implantable component 112, and the sound processing operations (e.g., conversion of sound to output signals) can be performed by a processor within the implantable component 112.
[0044] Return to Figure 1DIn a specific example, the output signal is provided to the RF module 122, which transmits the output signal (e.g., in an encoded manner) transcutaneously to the implantable component 112 via the external coil 108 and the implantable coil 114. That is, the output signal is received at the RF module 140 via the implantable coil 114 and provided to the stimulator unit 142. The stimulator unit 142 is configured to utilize the output signal to generate an electrical stimulation signal (e.g., a current signal) for delivery to the cochlea of the recipient. In this way, the cochlear implant system 102 electrically stimulates the auditory nerve cells of the recipient, thereby bypassing the missing or defective hair cells that normally convert acoustic vibrations into neural activity in a manner that causes the recipient to perceive one or more components of the received sound signal.
[0045] As detailed above, in the external hearing mode, the cochlear implant 112 receives processed sound signals from the sound processing unit 106. However, in the invisible hearing mode, the cochlear implant 112 is configured to capture and process sound signals for electrical stimulation of the recipient's auditory nerve cells. Specifically, the cochlear implant 112 includes at least one implantable sound sensor arrangement 150, which includes one or more implantable sound sensors (e.g., an implantable microphone and / or an implantable accelerometer).
[0046] Similar to the external sound processing module 124, the implantable sound processing module 158 may include, for example, one or more processors and a memory device (memory) including sound processing logic. The memory device may include any one or more of the following: non-volatile memory (NVM), ferroelectric random access memory (FRAM), read-only memory (ROM), random access memory (RAM), magnetic disk storage media devices, optical storage media devices, flash memory devices, electrical, optical or other physical / tangible memory storage devices. The one or more processors are, for example, microprocessors or microcontrollers that execute instructions of the sound processing logic stored in the memory device.
[0047] In the invisible hearing mode, the implantable sound sensor 150 may be combined with an implantable vibration sensor ( Figures 1A-1DThe implantable sound processing module 158 cooperates with one or more other implantable sensors (not shown) configured to detect / capture signals (e.g., acoustic sound signals, vibrations, etc.) that are provided to the implantable sound processing module 158. The implantable sound processing module 158 is configured to convert the received input signal (received at the implantable sound sensor 150) into an electrical signal for stimulating the first ear of the recipient, sometimes referred to herein as a sensed, received, or captured sound signal (i.e., the processing module 158 is configured to perform a sound processing operation). In other words, the one or more processors in the implantable sound processing module 158 are configured to execute the sound processing logic in the memory to convert the received sound signal into an output signal 156 that is provided to the stimulator unit 142. The stimulator unit 142 is configured to generate an electrical stimulation signal (e.g., an electric current signal) for delivery to the cochlea of the recipient using the output signal 156, thereby bypassing the missing or defective hair cells that normally convert the acoustic vibrations into neural activity.
[0048] It should be understood that the above description of the so-called external hearing mode and the so-called invisible hearing mode is merely illustrative, and that the cochlear implant system 102 may operate differently in different embodiments. For example, in an alternative embodiment of the external hearing mode, the cochlear implant 112 may generate stimulation signals for delivery to the recipient using the signals captured by the sound input device 118 and the implantable sound sensor 150. In other embodiments, the cochlear implant 112 may operate substantially or entirely without the external component 104. That is, in these embodiments, the cochlear implant 112 may operate substantially or entirely in the invisible hearing mode using the rechargeable battery 161. The rechargeable battery 161 may be recharged via an external charging device.
[0049] As described above, the cochlear implant system 102 operates by delivering stimulation signals (electric current) to the auditory system of the recipient, i.e., the spiral ganglion cells of the cochlea of the recipient. Typically, the human auditory system is composed of many structural components, some of which are widely connected by nerve cell bundles (neurons). Each nerve cell has a cell membrane that acts as a barrier to prevent the intercellular fluid from mixing with the extracellular fluid. The intercellular fluid and the extracellular fluid have different ion concentrations, which leads to a charge difference between the fluids. This charge difference across the cell membrane is referred to as the membrane potential (Vm) of the nerve cell in this article. The nerve cell uses the membrane potential to transmit signals between different parts of the auditory system.
[0050] In a nerve cell that is at rest (i.e., not transmitting a nerve signal), the membrane potential is called the resting potential of the nerve cell. Upon receiving a stimulus, the electrical properties of the nerve cell membrane undergo a sudden change, referred to herein as a nerve action potential or simply an action potential. An action potential represents a temporary depolarization or repolarization of the nerve cell membrane. An action potential causes an electrical signal to be transmitted along the conductive nucleus (axon) of a nerve cell. The signal can then be transmitted along a group of nerve cells via these propagated action potentials.
[0051] Figure 2 The various stages of an idealized action potential 262 are shown as the electrical potential passes through a nerve cell. The action potential is expressed as membrane voltage in millivolts (mV) versus time. Figure 2 The membrane voltages and times shown in are for illustrative purposes only, and the actual values may vary from individual to individual. Before applying stimulus 264 to the nerve cell, the resting potential of the nerve cell is about -70 mV. Stimulus 264 is applied at a first time. Under normal hearing, this stimulus is provided by the movement of the hair cells of the cochlea. The movement of these hair cells causes the release of neurotransmitters into the synaptic cleft, which in turn causes action potentials in the individual auditory nerve fibers. In a cochlear implant, stimulus 264 is an electrical stimulation signal (electrical stimulation).
[0052] After the stimulus 264 is applied, the nerve cell begins to depolarize. Depolarization of the nerve cell refers to the fact that the voltage of the cell becomes more positive after the stimulus 264. When the membrane of the nerve cell begins to depolarize beyond the critical threshold of the cell, the nerve cell undergoes an action potential. This action potential is sometimes referred to herein as the "excitation" or "activation" of the nerve cell. As used herein, the critical threshold of a nerve cell, a group of nerve cells, etc., refers to the threshold level at which a nerve cell, a group of nerve cells, etc. will experience an action potential. As used herein, "partial depolarization" or "partially depolarized" refers to a cell that has been depolarized to a level below / below the critical threshold of the cell (e.g., the cell is not activated / excited). In Figure 2 In the example shown in , the critical threshold level for firing a neuron is approximately -50 mV. For various receptors, the critical threshold and other transitions may be different, so Figure 2 The values provided are illustrative only.
[0053] The process of an illustrative action potential in a nerve cell can usually be divided into five stages. Figure 2 266, a peak phase 266, a falling phase 267, an undershoot phase 268, and a refractory phase (period) 269. During the rising phase 265, the membrane voltage continues to depolarize, and the point where the depolarization stops is shown as a peak phase 2666. Figure 2 In the example of FIG. 2 , during this peak phase 266 , the membrane voltage reaches a maximum value of approximately 40 mV.
[0054] After the peak phase 266, the action potential undergoes a falling phase 267. During the falling phase 267, the membrane voltage becomes increasingly negative, sometimes referred to as hyperpolarization of the nerve cell. This hyperpolarization causes the membrane voltage to temporarily become more negatively charged than when the nerve cell is at rest. This phase is referred to as the undershoot phase 268 of the action potential 262. After the peak phase 266, there is a period of time during which the nerve cell is impossible or difficult to excite. This period of time is referred to as the refractory phase (period) 269.
[0055] As described above, nerve cells must obtain a membrane voltage above a critical threshold before the nerve cells can be excited / activated. The number of nerve cells excited in response to electrical stimulation (current) can affect the "spatial range" of the electrical stimulation. As used herein, the spatial range of electrical stimulation (spatial stimulation range) refers to the amount of acoustic detail (e.g., spectral detail from (one or more) input acoustic sound signals) delivered by the electrical stimulation at the implanted electrodes in the cochlea and received accordingly by the primary auditory neurons (spiral ganglion cells). In other words, the spatial range refers to the width of the frequency axis (i.e., along the basilar membrane) of the region along which nerve cells are activated in response to the delivered stimulation (e.g., the focused amount). In general, the spatial range is proportional to the amount of current spread, meaning that a larger spatial range is associated with a larger current spread, while a smaller spatial range is associated with a smaller current spread.
[0056] There are different techniques for controlling the spatial extent of the electrical stimulation signal (e.g., to control the width along the frequency axis of the region of neural cells that are activated in response to the delivered stimulation). For example, the spatial extent of the electrical stimulation can be controlled, for example, by using different electrode configurations for a given stimulation channel to activate neural cell regions of different widths. For example, monopolar stimulation is an electrode configuration in which, for a given stimulation channel, current is "pulled" via one of the intracochlear electrodes 144, but the current is delivered by an electrode outside the cochlea (sometimes referred to as an extracochlear electrode (ECE) 139 ( Figure 1D )) "Injection". Monopolar stimulation typically exhibits a large degree of current spread (ie, a broad stimulation pattern) and therefore has a large spatial extent.
[0057] Other types of electrode configurations, such as tripolar, focused multipolar (FMP), also known as "phased array" stimulation, etc., typically reduce the size of the stimulated neural population by "pulling" current through one or more of the intracochlear electrodes 144 while also "injecting" current through one or more other adjacent intracochlear electrodes. Bipolar, tripolar, focused multipolar and other types of electrode configurations that both pull and inject current through the intracochlear electrodes are generally and collectively referred to herein as "focused" or "multipolar" stimulation. Compared to monopolar stimulation, focused stimulation typically exhibits a smaller degree of current spread (i.e., a narrow stimulation pattern) and therefore has a smaller spatial range than monopolar stimulation. Similarly, other types of electrode configurations, such as dual electrode patterns and wide channels, typically increase the size of the stimulated neural population by "pulling" current through multiple adjacent intracochlear electrodes.
[0058] Still other types of electrode configurations, sometimes referred to herein as focused or multipolar stimulation with partial far-field return, operate by pulling current out through one or more of the intracochlear electrodes 144 while also injecting current through one or more other adjacent intracochlear electrodes and the ECE 139. That is, in focused or multipolar stimulation with partial far-field return, the return current path is at least partially through the ECE 139, unlike full intracochlear multipolar stimulation in which current is injected only through the intracochlear electrodes 144. Multipolar stimulation with partial far-field return exhibits a degree of current spreading that is less than multipolar stimulation but greater than full intracochlear multipolar stimulation.
[0059] The cochlea is pure tone mapped, i.e., divided into regions, each of which responds to sound signals within a specific frequency range. Typically, the basal region of the cochlea responds to higher frequency sounds, while the more apical region of the cochlea responds to lower frequencies. The pure tone properties of the cochlea are fully utilized in cochlear implants so that specific acoustic frequencies are assigned to electrodes 144 of a stimulation assembly 116 positioned near corresponding pure tone regions of the cochlea (i.e., regions of the cochlea that will be naturally stimulated by acoustic frequencies in acoustic hearing). That is, in a cochlear implant, specific frequency bands are each mapped to a set of one or more electrodes for stimulating a selected (target) cochlear nerve cell population. The frequency bands and associated electrodes form a stimulation channel that delivers stimulation signals to the recipient.
[0060] In general, it is desirable that stimulation channels stimulate only narrow regions of neurons so that the resulting neural responses from adjacent stimulation channels have minimal overlap. Therefore, an ideal stimulation strategy in a cochlear implant would use focused stimulation / smaller spatial range to evoke the perception of all sound signals at any given time. Ideally, such a strategy would also enable each stimulation channel to stimulate a discrete pure tone region of the cochlea to better simulate natural hearing and achieve better perception of the details of the sound signal. However, although focused stimulation / smaller spatial range generally improves hearing performance, this improved hearing performance comes at the expense of higher stimulation current levels. That is, there is a tradeoff between the amount of stimulation power and the focus / spatial range. For example, it has been found that the current required for certain types of focused stimulation (e.g., to cause target neural cell excitation) can be sixty (60) current levels (CL) higher than the current required in monopolar stimulation in certain arrangements, which is equivalent to nearly quadrupling the current of focused stimulation relative to monopolar stimulation. This article presents the benefits of obtaining focused stimulation at lower overall current levels and therefore lower overall power consumption by delivering / applying facilitating signals and stimulation signals with different spatial ranges. For example, in some embodiments, a relatively less focused (relatively larger spatial extent) boost signal is delivered before or around a relatively more focused (relatively smaller spatial extent) stimulation signal. This arrangement can enable the use of lower current levels while still obtaining the benefits of focused stimulation (e.g., relatively narrow current spread).
[0061] More specifically, according to the embodiments presented herein, at least one boost signal having a first spatial range is used to partially depolarize the recipient's neural cells (e.g., only depolarize to a level below the critical threshold of the neural cells). Afterwards, at least one stimulation signal having a second spatial range is delivered to the partially depolarized neural cells to cause at least a subset of the partially depolarized neural cells to experience an action potential, and thus activate / excite. In certain embodiments presented herein, the second spatial range of at least one stimulation signal is smaller than the first spatial range (i.e., more focused, less current spread). In other words, in these embodiments, at least one boost signal having a relatively large current spread degree (i.e., a stimulation current having a larger spatial range) is delivered to "prepare" or "charge" a larger area of neural cells to a sub-excitation threshold, followed by delivery of at least one stimulation signal having a relatively small current spread degree (i.e., a stimulation current having a relatively small spatial range) to excite only a subset of prepared neural cells or a relatively small number of prepared neural cells. This particular combination of at least one less focused boost signal followed by at least one relatively more focused stimulation signal can require less stimulation current to obtain the benefits of traditional focused stimulation.
[0062] In other embodiments presented herein, the second spatial range of at least one stimulation signal is larger than the first spatial range of the boost signal (i.e., less focused, larger current spread). In other words, at least one boost signal with a relatively small current spread (i.e., a stimulation current with a small spatial range) is delivered to "prepare" or "charge" a smaller area of neural cells to a sub-excitation threshold, followed by delivery of at least one stimulation signal with a relatively large current spread (i.e., a stimulation current with a relatively large spatial range) to excite at least a subset of the prepared neural cells. This particular combination of at least one more focused boost signal followed by at least one relatively less focused stimulation signal may require less stimulation current to obtain the benefits of traditional focused stimulation.
[0063] Figure 3 is a schematic diagram illustrating the use of promotion signals according to various aspects of the technology presented herein. More specifically, Figure 3 A first biphasic boost signal 370 having a first spatial extent is shown being delivered to the nerve. Specifically, Figure 3 As shown in , the biphasic boost signal 370 includes a first boost pulse 371 (A) having a first polarity and a second boost pulse 371 (B) having a second polarity opposite to the first polarity. The biphasic boost signal 370 is delivered to the nerve cell (e.g., at an intensity / level, timing, etc.) to depolarize the nerve cell only to a level below the critical threshold of the nerve cell (e.g., partially depolarize the nerve cell). That is, the biphasic boost signal 370 is configured so that the nerve cell will not fire (e.g., will not undergo an action potential) in response to the biphasic boost signal 370 alone.
[0064] After the biphasic facilitation signal 370 is delivered, a biphasic stimulation signal 372 having a second spatial extent is delivered only to a subset of the neural cells depolarized by the biphasic facilitation signal 370. Figure 3 As shown in , biphasic stimulation signal 372 includes a first stimulation pulse 373 (A) having a first polarity and a second stimulation pulse 373 (B) having a second polarity opposite to the first polarity. Biphasic stimulation signal 372 is delivered to nerve cells (e.g., at an intensity / level, timing, etc.) to cause a subset of nerve cells to excite (e.g., undergo action potentials). This excitation of a subset of nerve cells causes a perception by the recipient. In the case of a cochlear implant, this perception is the perception of sound.
[0065] As mentioned above, in Figure 3In an example of the invention, the biphasic boost signal 370 has a first spatial extent and the biphasic stimulation signal 372 has a second spatial extent. In one example, the second spatial extent of the biphasic stimulation signal 372 is smaller (i.e., has a smaller current spread) than the first spatial extent of the biphasic boost signal 370. That is, according to certain embodiments, the biphasic boost signal 370 has a current spread that is relatively wider than the current spread of the biphasic stimulation signal 372. These relative differences in spatial extents can be the result of different electrode configurations, such as monopolar stimulation, wide / defocused stimulation, focused (i.e., multipolar current focused) stimulation, etc.
[0066] For example, Figure 4A , 4B 4C are schematic diagrams showing exemplary electrode currents and spatial extents for different channel configurations. It will be appreciated that Figures 4A-4C The spatial extent shown in is generally illustrative, and in practice, the stimulation current may spread differently in different recipients.
[0067] Figures 4A-4C Each of the figures shows a plurality of electrodes, shown as electrodes 444(1)-444(9), spaced apart along the recipient's cochlear frequency axis (ie, along the basilar membrane). Figures 4A-4C Solid lines of varying lengths extending from the various electrodes are also included to generally illustrate intracochlear stimulation currents 480(A)-480(E) delivered according to a particular channel configuration. However, it should be appreciated that in these embodiments, stimulation is delivered to the recipient using a charge-balanced waveform (e.g., biphasic current pulses) and that the stimulation is delivered to the recipient using a charge-balanced waveform (e.g., biphasic current pulses). Figures 4A-4C The length of the solid line extending from the electrode in each of the figures shows the relative "weights" of the two phases applied to the charge balance waveform at the corresponding electrode according to different channel configurations but different polarities of each phase. As further described below, different stimulation currents 480(A) and 480(C) (i.e., different channel weightings) produce different stimulation patterns 482(A) and 482(C) of voltage and neural excitation, respectively, along the frequency axis of the cochlea.
[0068] First reference Figure 4A , showing the use of a monopolar channel configuration, in which all intracochlear stimulation currents 480(A) are delivered with the same polarity via a single electrode 444(5). In this embodiment, the stimulation current 480(A) is injected by the extracochlear return contact, which has been removed from the cochlear return contact for ease of illustration. Figure 4A The intracochlear current 480(A) generates a current spreading pattern 482(A) where the current spreads across adjacent electrodes 444(3), 444(4), 444(6), and 444(7) as shown. The current spreading pattern 482(A) represents the spatial extent of the monopolar channel configuration.
[0069] Figure 4B and4C A focused channel configuration is shown in which an intra-cochlear compensation current is added to reduce the current spread along the frequency axis of the cochlea. The compensation current is delivered with a polarity opposite to that of the primary / main current. In general, the more compensation current is at nearby electrodes, the more focused the stimulation pattern produced (i.e., the smaller the width of the current spread pattern, and thus the smaller the spatial extent). That is, the spatial extent is reduced by introducing increasing large compensation currents on electrodes surrounding the central electrode with positive current.
[0070] More specifically, in Figure 4B , a current 480(B) of a first polarity is delivered via electrode 444(5), and a current 480(B) of an opposite polarity is delivered via adjacent electrodes, namely electrodes 444(3), 444(4), 444(6), and 444(7). The intracochlear current 480(B) produces a current spreading pattern 482(B), wherein, as shown, the current spreads only on electrodes 444(4)-444(6). Figure 4C , a current 480(C) of a first polarity is delivered via electrode 444(5), while a current 480(C) of an opposite polarity is delivered via adjacent electrodes, namely electrodes 444(3), 444(4), 444(6), and 444(7). The intracochlear current 480(C) produces a current diffusion pattern 482(C), which, as shown, is substantially confined to a spatial region adjacent to electrode 444(5).
[0071] Figure 4B and 4C The difference between the current spreading patterns 482(B) and 482(C) in FIG. 4 is due to the magnitude (i.e., weighting) of the currents of opposite polarity delivered via adjacent electrodes 444(3), 444(4), 444(6), and 444(7). Specifically, Figure 4B A partial focusing configuration is shown, where the compensation current does not completely cancel the main current on the central electrode, and the remaining current goes to the far-field extracochlear electrode (not shown). This is an example of stimulation using partial far-field return (e.g., multipolar stimulation with partial far-field return). Figure 4C is a fully focusing configuration in which the compensation current completely cancels the main current on the central electrode 444 ( 5 ) (ie, no far-field extra-cochlear electrodes are used).
[0072] As stated, Figure 3 Embodiments are shown in which a biphasic signal is used as a facilitating signal to partially depolarize neural cells prior to delivering a biphasic stimulation signal to cause a subset of partially depolarized neural cells to fire (e.g., a monopolar biphasic conditioning signal followed by a more focused biphasic stimulation signal or a more focused biphasic conditioning signal followed by a monopolar biphasic stimulation signal). Figure 3In an embodiment, the charge associated with the boost signal is collected prior to delivering the stimulation signal. Figure 5A An alternative embodiment is shown in which the charge associated with the boost signal is not collected until after the stimulation signal is delivered. That is, Figure 5A Embodiments are shown in which the stimulation signal will split the facilitation signal (eg, a split monopolar facilitation signal with an intervening multipolar stimulation signal).
[0073] More specifically, Figure 5A A boost signal 570 (A) is shown consisting of a first monophasic boost pulse 571 (A) having a first polarity and a second monophasic boost pulse 571 (B) having a second polarity opposite the first polarity. Figure 5A Also shown is a biphasic stimulation signal 572(A), which is composed of a first stimulation pulse 573(A) having a first polarity and a second stimulation pulse 573(B) having a second polarity opposite to the first polarity. As shown, the biphasic stimulation signal 572(A) (i.e., stimulation pulses 573(A) and 573(B)) is delivered between the boost pulses 571(A) and 571(B) of the boost signal 570(A). That is, in this embodiment, the boost signal 570(A) surrounds the stimulation signal 572(A).
[0074] according to Figure 5A In an embodiment, monophasic facilitation pulses 571(A) and 571(B) of facilitation signal 570(A) are delivered to the nerve using an electrode configuration having an associated first spatial extent, while stimulation pulses 573(A) and 573(B) of stimulation signal 572(A) are delivered to the nerve using an electrode configuration having an associated second spatial extent that is smaller than the first spatial extent. In other words, stimulation pulses 573(A) and 573(B) are configured so as to produce a current spread that is smaller than the current spread produced by facilitation pulses 571(A) and 571(B).
[0075] exist Figure 5A In the example of , boost pulse 571(A) is delivered to the nerve cell (e.g., at an intensity / level, timing, etc.) to depolarize the nerve cell only to a level below a critical threshold of the nerve cell. That is, boost pulse 571(A) is configured such that the nerve cell does not fire (e.g., does not undergo an action potential) solely in response to boost pulse 571(A).
[0076] After delivery of the boost pulse 571(A), a biphasic stimulation signal 572(A) (having a second spatial extent) is delivered only to a subset of the nerve cells depolarized by the boost pulse 571(A). The biphasic stimulation signal 572(A) is delivered (e.g., at an intensity / level, timing, etc.) to the nerve cells to cause the subset of nerve cells to excite (e.g., undergo action potentials). This excitation of the subset of nerve cells causes a perception by the recipient. In the case of a cochlear implant, this perception is the perception of sound. After delivery of the biphasic stimulation signal 572(A), a boost pulse 571(B) is delivered to balance the charge in the nerve cells (e.g., to remove the charge introduced by the boost pulse 571(A)).
[0077] As mentioned above, in Figure 5A In the examples of FIG. 5 , pulses 571(A) and 571(B) have a first spatial extent, and stimulation pulses 573(A) and 573(B) have a second spatial extent (i.e., a smaller current spread) that is smaller than the first spatial extent. That is, according to these embodiments, boost signal 570(A) has a current spread that is relatively wider than the current spread of biphasic stimulation signal 572(A). The relative difference in these spatial extents can be, for example, a reference to Figures 4A-4C Results of different electrode configurations described, such as monopolar stimulation, broad / defocused stimulation, focused (e.g., multipolar current focusing) stimulation, etc.
[0078] Figure 5B A boost signal 570 (B) is shown consisting of a first monophasic boost pulse 571 (A) having a first polarity and a second monophasic boost pulse 571 (B) having a second polarity opposite to the first polarity. Figure 5B Also shown is a biphasic stimulation signal 572(B), which consists of a first stimulation pulse 573(A) having a first polarity and a second stimulation pulse 573(B) having a second polarity opposite to the first polarity. As shown, the biphasic boost signal 570(B) (i.e., boost pulses 571(A) and 571(B)) is delivered between the stimulation pulses 573(A) and 573(B) of the stimulation signal 572(B). That is, in this embodiment, the stimulation signal 572(B) surrounds the boost signal 570(B).
[0079] according to Figure 5B In an embodiment, boost pulses 571(A) and 571(B) of boost signal 570(B) are delivered to the nerve using an electrode configuration having an associated first spatial extent, while stimulation pulses 573(A) and 573(B) of stimulation signal 572(B) are delivered to the nerve using an electrode configuration having an associated second spatial extent that is smaller than the first spatial extent. In other words, stimulation pulses 573(A) and 573(B) are configured so as to produce a current spread that is smaller than the current spread produced by boost pulses 571(A) and 571(B).
[0080] Figure 3 , 5A 5B generally illustrate embodiments in which boost signals and stimulation signals having different spatial extents are delivered via the same stimulation channel (eg, the same electrode or set of electrodes). Figure 3 , 5A 5B also show an embodiment where there is a one-to-one correspondence between the facilitation signal and the stimulation signal. It should be recognized that these embodiments are merely illustrative, and that the facilitation signal and the stimulation signal may be delivered in different combinations on different combinations of stimulation channels. Fig. 6A , 6B and 6C illustrate several such alternative embodiments.
[0081] First reference Fig. 6A , shows an embodiment in which a boost signal 670 is delivered via a stimulation channel (e.g., one or more electrodes) 682(2). The boost signal 670 is composed of a first monophasic boost pulse 671(A) having a first polarity and a second monophasic boost pulse 671(B) having a second polarity opposite to the first polarity. The boost pulse 671(A) is delivered, for example, at an intensity / level, timing, etc. to depolarize a region of a nerve cell (e.g., only to a level below a critical threshold of the nerve cell). That is, the boost pulse 671(A) is configured so that the nerve cell does not excite (e.g., does not undergo an action potential) solely in response to the boost pulse 671(A).
[0082] Fig. 6A Also shown is the delivery of three biphasic stimulation signals (referred to as stimulation signals 672, 676, and 678) to a subset of partially depolarized neural cells following delivery of boost signal 670. In this example, stimulation signal 672 is delivered via stimulation channel 682(2) (i.e., the same stimulation channel used to deliver boost signal 670), while stimulation signals 676 and 678 are delivered via different stimulation channels, referred to as stimulation channels 682(1) and 682(2), respectively.
[0083] As shown, stimulation signal 672 is composed of a first stimulation pulse 673(A) having a first polarity and a second stimulation pulse 673(B) having a second polarity opposite to the first polarity of first stimulation pulse 673(A). Similarly, stimulation signal 674 is composed of a first stimulation pulse 675(A) having a first polarity and a second stimulation pulse 675(B) having a second polarity opposite to the first polarity of first stimulation pulse 675(A). Finally, stimulation signal 676 is composed of a first stimulation pulse 677(A) having a first polarity and a second stimulation pulse 677(B) having a second polarity opposite to the first polarity of first stimulation pulse 677(A).
[0084] according to Fig. 6A In an embodiment, a boost signal 670 is delivered to a nerve using an electrode configuration having an associated first spatial extent, while stimulation signals 672, 674, and 676 are delivered to the nerve using one or more electrode configurations having an associated spatial extent that is greater than the first spatial extent. In other words, stimulation signals 672, 674, and 676 are each configured so as to produce a current spread that is smaller than the current spread produced by boost signal 670. Stimulation signals 672, 674, and 676 may be delivered using the same electrode configuration or using different electrode configurations having different spatial extents. That is, in some embodiments, stimulation signal 672 may be delivered using one electrode configuration, while stimulation signals 674 and 676 are delivered using the same or different electrode configurations. However, as described above, the electrode configurations used to deliver stimulation signals 672, 674, and 676 each have a larger spatial extent than the electrode configuration used to deliver boost signal 670. The relative differences in these spatial extents may be, for example, reference to Figures 4A-4C Results of different electrode configurations described, such as monopolar stimulation, broad / defocused stimulation, focused (e.g., multipolar current focusing) stimulation, etc.
[0085] exist Fig. 6A In the example of FIG. 6A , boost pulse 671(A) is delivered, for example, at an intensity / level, timing, etc., to partially depolarize a region of a nerve cell (e.g., only to a level below a critical threshold of the nerve cell). That is, boost pulse 671(A) is configured such that the nerve cell does not fire (e.g., does not undergo an action potential) solely in response to boost pulse 671(A). The region of the nerve cell that is partially depolarized in response to boost signal 670 is Figure 6B 684. In this example, boost pulse 671 (B) is used for charge balancing.
[0086] As described, after delivery of the boost signal 670, three stimulation signals 672, 674, and 676 are delivered to a subset of partially depolarized neural cells 684. Figure 6B In FIG. 6 , these subsets are represented by dashed ovals 685(2), 685(1), and 685(3) with vertical lines. The regions of excited / activated neurons are Figure 6B In FIG. 6 , the intersection of the horizontal line and the vertical line is represented. That is, the stimulation signal 672 is delivered to the subset 685(2) of the partially depolarized nerve cells 684, the stimulation signal 674 is delivered to the subset 685(2) of the partially depolarized nerve cells 684, and the stimulation signal 676 is delivered to the subset 685(3) of the partially depolarized nerve cells 684.
[0087] It should be recognized that Fig. 6AThe specific combinations of facilitatory and stimulatory signals shown in are illustrative only, and facilitatory and stimulatory signals may be delivered in various combinations in accordance with the embodiments presented herein.
[0088] For example, Figure 6C Shown with Fig. 6A An embodiment similar to the embodiment of , except that no stimulation signal is delivered on stimulation channel 682(2) (i.e., stimulation signal 672 is omitted). Fig.6D Shown with Fig. 6A , except that the boost signal 670 is wrapped around the stimulation signals 672, 674, and 676. That is, in Fig.6D In an embodiment, a monophasic boost pulse 671 (A) is delivered prior to biphasic stimulation signals 672, 674, and 676 to partially depolarize a region of nerve cell 684. However, boost pulse 671 (B) is not delivered until after biphasic stimulation signals 672, 674, and 676 for charge balancing of boost pulse 671 (A). Although this stimulation may cause other time issues where charge must be restored over time, it illustrates that there are various embodiments of boost stimulation. In another example, boost signal 670 may continue to be delivered during the delivery of one or more of biphasic stimulation signals 672, 674, and 676. Fig. 6E Yet another example is shown in which a boost signal 670 is delivered after delivery of one or more of the biphasic stimulation signals 672 , 674 , and 676 .
[0089] Figure 7 790 is a flow chart of an exemplary method 790 according to embodiments presented herein. The method 790 begins at 792, where at least one stimulating signal having a first spatial extent is delivered to partially depolarize neural cells of a recipient. At 794, at least one stimulating signal having a second spatial extent is delivered to activate at least a subset of the partially depolarized neural cells of the recipient, where the second spatial extent is different from the first spatial extent.
[0090] Figure 8 890 begins at 892, where at least one boost pulse is delivered to a neural cell region using a first electrode configuration associated with a first current spread. At 894, after delivering the at least one boost pulse, at least one biphasic stimulation signal is delivered to at least a portion of the neural cell region using a second electrode configuration associated with a second current spread different from the first current spread.
[0091] As previously mentioned, the technology disclosed herein can be applied to any of a variety of situations and used with a variety of different devices. For example, Figure 9-11An exemplary device configured to deliver a facilitating signal and a stimulating signal as described above according to an embodiment presented herein is shown. As further described below, Fig. 9 An exemplary implantable stimulation system is shown, Fig. 9 An exemplary vestibular stimulator is shown, Fig.10 A retinal prosthesis is shown. The technology of the present disclosure can be applied to other medical devices, such as neurostimulators, pacemakers, defibrillators, sleep apnea management stimulators, epilepsy treatment stimulators, tinnitus management stimulators, and vestibular stimulation devices, as well as other medical devices that deliver stimulation to tissue. In addition, the technology described herein can also be applied to consumer devices. These various systems and devices can benefit from the technology described herein.
[0092] Fig. 9 is a functional block diagram of an implantable stimulator system 900 that can benefit from the technology described herein. The implantable stimulator system 900 includes a wearable device 906 that acts as an external processor device and an implantable device 912 that acts as an implanted stimulator device. In an example, the implantable device 912 is an implantable stimulator device that is configured to be implanted below the tissue (e.g., skin) of the recipient. In an example, the implantable device 912 includes a biocompatible implantable housing 938. Here, the wearable device 906 is configured to be percutaneously connected to the implantable device 912 via a wireless connection to provide additional functionality to the implantable device 912.
[0093] In the example shown, the wearable device 906 includes one or more sensors 911, a processor 924, a transceiver 922, and a power supply 932. The one or more sensors 911 may be one or more units configured to generate data based on sensed activity. In the example where the stimulation system 900 is a hearing prosthesis system, the one or more sensors 911 include a sound input sensor, such as a microphone, an electrical input for an FM hearing system, other components for receiving sound input, or a combination thereof. In the case where the stimulation system 900 is a visual prosthesis system, the one or more sensors 911 may include one or more cameras or other visual sensors. In the case where the stimulation system 900 is a cardiac stimulator, the one or more sensors 911 may include a cardiac monitor. The processor 924 may be a component (e.g., a central processing unit) configured to control the stimulation provided by the implantable device 912. The stimulation may be controlled based on data from the sensor 911, a stimulation schedule, or other data. In the case where the stimulation system 900 is a hearing prosthesis, the processor 924 may be configured to convert a sound signal received from (one or more) sensors 911 (e.g., acting as a sound input unit) into a signal 951. The transceiver 922 is configured to transmit a signal 951 in the form of a power signal, a data signal, a combination thereof (e.g., by interleaving the signal), or other signals. The transceiver 922 may also be configured to receive power or data. The stimulation signal may be generated by the processor 924 and transmitted to the implantable device 912 using the transceiver 922 for providing stimulation.
[0094] In the illustrated example, the implantable device 912 includes a transceiver 922, a power source 932, and a medical device 913 including an electronic module 917 and a stimulation device 916. The electronic module 917 may include one or more other components to provide medical device functions. In many examples, the electronic module 917 includes one or more components for receiving a signal and converting the signal into a stimulation signal 915. The electronic module 917 may also include a stimulator unit. The electronic module 917 may generate a stimulation signal 915 or control the delivery of the stimulation signal to the stimulation device 916. In an example, the electronic module 917 includes one or more processors (e.g., a central processing unit or a microcontroller) connected to a memory component (e.g., a flash memory), the memory component storing instructions that, when executed, cause an operation to be performed. In an example, the electronic module 917 generates and monitors parameters (e.g., output voltage, output current, or line impedance) associated with generating and delivering stimulation. In an example, the electronic module 917 generates a telemetry signal (e.g., a data signal) including telemetry data. The electronic module 917 may transmit the telemetry signal to the wearable device 906 or store the telemetry signal in a memory for later use or retrieval.
[0095] Stimulation device 916 can be a component configured to provide stimulation to the target tissue. In the example shown, stimulation device 916 is an electrode assembly including an array of electrode contacts disposed on a lead. The lead can be disposed close to the tissue to be stimulated. In the case where system 900 is a cochlear implant system, stimulation device 916 can be inserted into the cochlea of the recipient. Stimulation device 916 can be configured to deliver a stimulation signal 915 (e.g., an electrical stimulation signal) generated by electronic module 917 to the cochlea so that the recipient experiences auditory perception. In other examples, stimulation device 916 is a vibration actuator disposed inside or outside the housing of implantable device 912 and configured to generate vibrations. The vibration actuator receives stimulation signal 915 and generates a mechanical output force in the form of vibrations based on the stimulation signal. The actuator can deliver vibrations to the recipient's skull in a manner that generates movement or vibration of the recipient's skull, thereby generating auditory perception by activating the hair cells in the recipient's cochlea via cochlear fluid movement.
[0096] The transceiver 922 may be a component configured to transcutaneously receive and / or transmit a signal 951 (e.g., a power signal and / or a data signal). The transceiver 922 may be a collection of one or more components that form part of a transcutaneous energy or data transmission system to transmit a signal 951 between the wearable device 906 and the implantable device 912. Various types of signal transmission, such as electromagnetic, capacitive, and inductive transmission, may be used to effectively receive or transmit the signal 951.
[0097] Each transceiver in the transceiver 922 may include or may be electrically connected to a corresponding coil 914 for transcutaneous transmission of power and / or data. The power supply 932 may be one or more components configured to provide operating power to other components. The power supply 932 may be or include one or more rechargeable batteries. The power of the battery may be received from the power supply and stored in the battery. The power may then be distributed to other components for operation as needed.
[0098] It should be understood that although the combination Fig. 9 Although specific components are described, the technology disclosed herein can be applied to any of a variety of situations. The above discussion is not intended to indicate that the disclosed technology is only suitable for use in similar Fig. 9 In general, the methods and systems herein may be practiced using additional configurations and / or some aspects described may be excluded without departing from the methods and systems disclosed herein.
[0099] Fig.10An exemplary vestibular stimulator system 1002 is shown, which can be used to implement the embodiments presented herein. As shown, the vestibular stimulator system 1002 includes an implantable component (vestibular stimulator) 1012 and an external device / component 1004 (e.g., an external processing device, a battery charger, a remote controller, etc.). The external device 1004 includes a transceiver unit 1060. Thus, the external device 1004 is configured to transmit data (and possibly power) to the vestibular stimulator 1012.
[0100] The vestibular stimulator 1012 includes an implant body (main module) 1034, a lead region 1036, and a stimulation assembly 1016, all configured to be implanted below the skin / tissue (tissue) 1015 of a recipient. The implant body 1034 generally includes an airtight sealed housing 1038 in which an RF interface circuit system, one or more rechargeable batteries, one or more processors, and a stimulator unit are disposed. The implant body 134 also includes an internal / implantable coil 1014, which is generally external to the housing 1038 but connected to a transceiver via an airtight feedthrough (not shown).
[0101] In some embodiments, the external device 1004 and / or the vestibular stimulator 1012 may include one or more body motion sensors (e.g., accelerometers, gyroscopes, etc.) configured to capture motion signals associated with movement of the head or other parts of the recipient's body (e.g., capturing angular acceleration of the head).
[0102] The stimulation assembly 1016 includes a plurality of electrodes 1044(1)-(3) disposed in a carrier member (e.g., a flexible silicone body). In this particular example, the stimulation assembly 1016 includes three (3) stimulation electrodes, referred to as stimulation electrodes 1044(1), 1044(2), and 1044(3). The stimulation electrodes 1044(1), 1044(2), and 1044(3) serve as an electrical interface for delivering electrical stimulation signals to the vestibular system of a recipient.
[0103] The stimulation assembly 1016 is configured so that a surgeon can implant the stimulation assembly near the recipient's otolith organ via, for example, the recipient's oval window. It should be appreciated that this particular embodiment with three stimulation electrodes is merely illustrative, and the techniques presented herein can be used with stimulation assemblies with different numbers of stimulation electrodes, stimulation assemblies with different lengths, etc.
[0104] Fig.11A retinal prosthesis system 1101 is shown that includes an external device 1110 configured to communicate with a retinal prosthesis 1100 via a signal 1151. The retinal prosthesis 1100 includes an implanted processing module 1125, and a retinal prosthesis sensor-stimulator 1190 is positioned proximate to the recipient's retina. The external device 1110 and the processing module 1125 can communicate via coils 1108, 1114.
[0105] In an example, sensory input (e.g., photons entering the eye) is absorbed by a microelectronic array of a sensor-stimulator 1190 that is hybridized with a glass piece 1192 that includes, for example, an embedded microwire array. The glass may have a curved surface that conforms to the inner radius of the retina. The sensor-stimulator 1190 may include a microelectronic imaging device that may be made of thin silicon containing an integrated circuit system that converts incident photons into electronic charges.
[0106] The processing module 1125 includes an image processor 1123 that communicates with the sensor-stimulator 1190 signals via, for example, leads 1188 extending through a surgical incision 1189 formed in the eye wall. In other examples, the processing module 1125 communicates with the sensor-stimulator 1190 wirelessly. The image processor 1123 processes the input of the sensor-stimulator 1190 and provides control signals back to the sensor-stimulator 1190 so that the device can provide an output to the optic nerve. That is, in an alternative example, the processing is performed by a component adjacent to or integrated with the sensor-stimulator 1190. The charge generated by the conversion of the incident photons is converted into a proportional amount of electronic current, which is input to the nearby retinal cell layer. The cells are excited, and signals are sent to the optic nerve, thereby inducing visual perception.
[0107] The processing module 1125 may be implanted in the recipient and function by communicating with an external device 1110, such as a behind-the-ear unit, a pair of glasses, etc. The external device 1110 may include an external light / image capture device (e.g., located in / on the behind-the-ear unit or a pair of glasses, etc.), while, as noted above, in some examples, the light / image is captured by a sensor-stimulator 1190 that is implanted in the recipient.
[0108] It should be understood that although specific uses of the present technology have been illustrated and discussed above, the disclosed technology can be used with various devices according to many examples of the present technology. The above discussion is not intended to indicate that the disclosed technology is only suitable for implementation in systems similar to those shown in the accompanying drawings. In general, additional configurations can be used to practice the processes and systems herein, and / or some aspects described can be excluded without departing from the processes and systems disclosed herein.
[0109] The present disclosure describes some aspects of the present invention technology with reference to the accompanying drawings, in which only some possible aspects are shown. However, other aspects may be embodied in many different forms and should not be construed as being limited to the aspects set forth herein. Instead, these aspects are provided to make the present disclosure detailed and complete and to fully convey the scope of possible aspects to those skilled in the art.
[0110] It should be understood that the various aspects (e.g., parts, components, etc.) described herein with respect to the figures are not intended to limit the systems and processes to the specific aspects described. Therefore, additional configurations can be used to practice the methods and systems herein, and / or some aspects described can be excluded without departing from the methods and systems disclosed herein.
[0111] According to certain aspects, a system and a non-transitory computer-readable storage medium are provided. The system is configured with hardware, and the hardware is configured to perform operations similar to the method of the present disclosure. One or more non-transitory computer-readable storage media include instructions, and the instructions, when executed by one or more processors, cause the one or more processors to perform operations similar to the method of the present disclosure.
[0112] Similarly, where steps of a process are disclosed, these steps are described for the purpose of illustrating the present methods and systems, and are not intended to limit the present disclosure to a particular sequence of steps. For example, the steps may be performed in a different order, two or more steps may be performed simultaneously, additional steps may be performed, and disclosed steps may be eliminated without departing from the present disclosure. Furthermore, the disclosed processes may be repeated.
[0113] Although specific aspects are described herein, the scope of the present technology is not limited to these specific aspects. Those skilled in the art will recognize other aspects or improvements within the scope of the present technology. Therefore, specific structures, actions or media are disclosed only as illustrative aspects. The scope of the present technology is limited by the following claims and any equivalents therein.
[0114] It should also be understood that the embodiments presented herein are not mutually exclusive and that various embodiments can be combined with another embodiment in any of a variety of different ways.
Claims
1. A method comprising: delivering at least one facilitatory signal having a first spatial extent to partially depolarize a neural cell of a recipient; as well as delivering at least one stimulation signal having a second spatial extent to activate at least a subset of the partially depolarized neural cells of the recipient, The second spatial range is different from the first spatial range. The method according to claim 1 , wherein the second spatial range is smaller than the first spatial range. The method according to claim 1 , wherein the second spatial range is larger than the first spatial range.
4. The method of claim 1, 2 or 3, wherein the at least one boost signal comprises a first boost pulse having a first polarity and a second boost pulse having a second polarity.
5. The method of claim 4, wherein delivering the at least one facilitatory signal having the first spatial extent to depolarize the neural cell portion of the recipient comprises: The first boost pulse and the second boost pulse are delivered prior to delivering the at least one stimulation signal.
6. The method of claim 4, wherein delivering the at least one facilitatory signal having the first spatial extent to depolarize the neural cell portion of the recipient comprises: The first boost pulse and the second boost pulse are delivered after delivery of the at least one stimulation signal.
7. The method of claim 4, wherein delivering the at least one facilitatory signal having the first spatial extent to depolarize the neural cell portion of the recipient comprises: delivering the first boost pulse prior to delivering the at least one stimulation signal; as well as The second boost pulse is delivered after delivery of the at least one stimulation signal.
8. The method of claim 1, 2 or 3, wherein delivering at least one facilitatory signal having a first spatial extent to partially depolarize a recipient's neural cells comprises: The at least one facilitation signal is delivered via a monopolar electrode configuration.
9. The method of claim 1, 2 or 3, wherein delivering the at least one stimulation signal having the second spatial extent to activate at least the subset of the partially depolarized neural cells of the recipient comprises: The at least one stimulation signal is delivered using a multipolar electrode configuration.
10. The method of claim 1, 2 or 3, wherein delivering the at least one stimulation signal having the second spatial extent to activate at least the subset of the partially depolarized neural cells of the recipient comprises: The at least one stimulation signal is delivered via a multipolar electrode configuration with partial far-field return.
11. The method according to claim 1, 2 or 3, further comprising: The at least one facilitating signal and the at least one stimulating signal are delivered via the same stimulation channel.
12. The method according to claim 1, 2 or 3, further comprising: delivering the at least one facilitatory signal via a first stimulation pathway; as well as The at least one stimulation signal is delivered via a second stimulation channel different from the first stimulation channel.
13. The method of claim 1, 2 or 3, wherein delivering the at least one stimulation signal having a second spatial extent to activate at least a subset of the partially depolarized neural cells of the recipient comprises: A plurality of stimulation signals are delivered to the recipient, wherein each of the stimulation signals has an associated spatial extent that is greater than a spatial extent of the first spatial extent.
14. The method of claim 13, wherein delivering the plurality of stimulation signals to the recipient comprises: Two or more of the plurality of stimulation signals are delivered via different stimulation channels.
15. The method according to claim 14, further comprising: The two or more stimulation signals of the plurality of stimulation signals are delivered in parallel.
16. The method of claim 13, wherein delivering the plurality of stimulation signals to the recipient comprises: Two or more stimulation signals of the plurality of stimulation signals are delivered sequentially via the same stimulation channel.
17. A method comprising: delivering at least a first facilitating pulse having a first polarity to the region of neural cells using a first electrode configuration associated with a first current spread; as well as After delivering the at least first boost pulse, at least one biphasic stimulation signal is delivered to only at least a portion of the neural cell region using a second electrode configuration associated with a second current spread that is different from the first current spread. The method of claim 17 , wherein the second current spread is smaller than the first current spread. The method of claim 17 , wherein the second current spread is greater than the first current spread.
20. The method of claim 17, wherein the at least first boost pulse is configured to only partially depolarize the region of nerve cells.
21. The method of claim 17, 18, 19 or 20, further comprising: Prior to delivering the at least one biphasic stimulation signal, at least a second facilitating pulse having a second polarity is delivered to the neural cell region using the associated first electrode configuration.
22. The method of claim 17, 18, 19 or 20, further comprising: After delivering the at least one biphasic stimulation signal, at least a second facilitating pulse having a second polarity is delivered to the neural cell region using the associated first electrode configuration.
23. The method of claim 17, 18, 19 or 20, wherein delivering the at least a first facilitating pulse to the region of neural cells comprises: The at least first boost pulse is delivered via a monopolar electrode configuration.
24. The method of claim 17, 18, 19 or 20, further comprising: delivering the at least first boost pulse via a first multipolar electrode configuration; as well as The at least one biphasic stimulation signal is delivered using an associated second multipolar electrode configuration.
25. The method of claim 17, 18, 19 or 20, wherein delivering the at least one biphasic stimulation signal comprises: The at least one biphasic stimulation signal is delivered using a multipolar electrode configuration.
26. The method of claim 17, 18, 19 or 20, wherein delivering the at least one biphasic stimulation signal comprises: The at least one biphasic stimulation signal is delivered via a multipolar electrode configuration with partial far-field return.
27. The method of claim 17, 18, 19 or 20, further comprising: The at least first boost pulse and the at least one biphasic stimulation signal are delivered via the same stimulation channel.
28. The method of claim 17, 18, 19 or 20, further comprising: delivering the at least first boost pulse via a first stimulation channel; as well as The at least one biphasic stimulation signal is delivered via a second stimulation channel different from the first stimulation channel.
29. The method of claim 17, 18, 19 or 20, wherein delivering the at least one biphasic stimulation signal comprises: A plurality of stimulation signals are delivered to one or more portions of the neural cell region, wherein each stimulation signal of the plurality of stimulation signals is delivered using a corresponding electrode configuration having an associated current spread that is less than the first current spread.
30. The method of claim 29, wherein delivering the plurality of stimulation signals comprises: Two or more of the plurality of stimulation signals are delivered via different electrode configurations.
31. The method of claim 29, wherein delivering the plurality of stimulation signals comprises: The two or more stimulation signals of the plurality of stimulation signals are delivered to different portions of the neural cell region via different stimulation channels.
32. The method of claim 31 further comprising: The two or more stimulation signals of the plurality of stimulation signals are delivered in parallel.
33. The method of claim 31 , further comprising: The two or more stimulation signals of the plurality of stimulation signals are delivered sequentially via the same stimulation channel.
34. An implantable medical device comprising: one or more input devices configured to receive at least one input signal; one or more processors configured to convert the at least one input signal into at least one output signal; an electrode array configured to be implanted in a recipient; as well as a stimulator unit configured to generate at least one electrical stimulation signal based on the at least one output signal and to deliver the at least one electrical stimulation signal to a cell region of the recipient via the electrode array, Wherein, before delivering the at least one electrical stimulation signal to the cell region, the stimulator unit is configured to generate at least a first boost pulse and deliver the at least first boost pulse to the cell region via the electrode array, wherein the at least first boost pulse is delivered via a first electrode configuration and is configured to depolarize only the cell portion within the cell region.
35. An implantable medical device according to claim 34, wherein the stimulator unit is configured to generate at least a second boost pulse and deliver the at least second boost pulse to the cell area after delivering the at least one electrical stimulation signal to the cell area.
36. An implantable medical device according to claim 34, wherein the stimulator unit is configured to generate at least a second boost pulse and deliver the at least second boost pulse to the cell area before delivering the at least one electrical stimulation signal to the cell area.
37. An implantable medical device according to claim 34, 35 or 36, wherein the stimulator unit is configured to deliver the at least one electrical stimulation signal via a second electrode configuration different from the first electrode configuration.
38. The implantable medical device of claim 37, wherein the first electrode configuration is associated with a first current spreading and the second electrode configuration is associated with a second current spreading, the second current spreading being different from the first current spreading.
39. The implantable medical device of claim 38, wherein the first current spread is greater than the second current spread.
40. The implantable medical device of claim 38, wherein the first current spread is less than the second current spread.
41. An implantable medical device according to claim 37, wherein the stimulator unit is configured to deliver the at least one boost pulse using a monopolar electrode configuration.
42. An implantable medical device according to claim 41, wherein the stimulator unit is configured to deliver the at least one stimulation signal using a multipolar electrode configuration.
43. An implantable medical device according to claim 41, wherein the stimulator unit is configured to deliver the at least one stimulation signal using a multipolar electrode configuration with partial far-field return.
44. An implantable medical device according to claim 37, wherein the stimulator unit is configured to deliver at least one boost pulse signal and the at least one stimulation signal via the same stimulation channel.
45. An implantable medical device according to claim 37, wherein the stimulator unit is configured to deliver at least one boost pulse signal via a first stimulation channel and to deliver the at least one stimulation signal via a second stimulation channel, the second stimulation channel being different from the first stimulation channel.
46. An implantable medical device according to claim 34, 35 or 36, wherein in order to deliver the at least one stimulation signal, the stimulator unit is configured to deliver multiple stimulation signals to the cell area, wherein each of the stimulation signals is delivered using an electrode configuration associated with current spreading, which is different from the current spreading associated with the first electrode configuration.
47. An implantable medical device according to claim 46, wherein the stimulator unit is configured to deliver two or more stimulation signals of the plurality of stimulation signals via different stimulation channels.
48. The implantable medical device of claim 47, wherein the stimulator unit is configured to deliver the two or more stimulation signals of the plurality of stimulation signals in parallel.
49. An implantable medical device according to claim 46, wherein the stimulator unit is configured to sequentially deliver the two or more stimulation signals of the plurality of stimulation signals via the same stimulation channel.
50. A medical device comprising: one or more processors; as well as At least one stimulator unit, the at least one stimulator unit being configured to: generating at least a first boost pulse having a first polarity, delivering the at least a first facilitating pulse to a region of cells of a recipient using a first electrode configuration having an associated first current spread, generating at least one stimulation signal in response to instructions received from the one or more processors, and After delivering the at least first boost pulse, the at least one stimulation signal is delivered to the region of cells of the recipient using a second electrode configuration having an associated second current spread different from the first current spread.
51. The medical device of claim 50, wherein the second current spread is smaller than the first current spread.
52. The medical device of claim 50, wherein the second current spread is greater than the first current spread.
53. The medical device of claim 50, wherein the at least first boost pulse is configured to depolarize only a portion of the cell region.
54. A medical device according to claim 50, 51, 52 or 53, wherein the stimulator unit is configured to deliver at least a second boost pulse having a second polarity to the cell area using the first electrode configuration prior to delivering the at least one stimulation signal.
55. The medical device of claim 50, 51, 52 or 53, wherein the medical device comprises one or more input devices configured to receive at least one input signal, and wherein the at least one stimulation signal is generated based on the at least one input signal.
56. The medical device of claim 55, wherein the at least one input signal comprises at least one ambient signal captured from the recipient's surrounding environment.
57. The medical device of claim 56, wherein the one or more input devices include one or more sound inputs, and wherein at least one ambient signal includes a sound signal.
58. The medical device of claim 56, wherein the at least one ambient signal comprises a light signal.
59. The medical device of claim 55, wherein the one or more input devices include one or more body motion sensors.
60. The medical device of claim 50, 51, 52 or 53, wherein the stimulator unit is configured to deliver the at least first boost pulse to the cell region using a monopolar electrode configuration.
61. A medical device according to claim 50, 51, 52 or 53, wherein the stimulator unit is configured to deliver the at least first boost pulse via a first multipolar electrode configuration and to deliver the at least one stimulation signal using a second multipolar electrode configuration.
62. The medical device of claim 50, 51, 52 or 53, wherein the stimulator unit is configured to deliver the at least one stimulation signal using a multipolar electrode configuration.
63. The medical device of claim 50, 51, 52 or 53, wherein the stimulator unit is configured to deliver the at least one stimulation signal using a multipolar electrode configuration with partial far-field return.
